Tarsus Pharmaceuticals, Inc.
TARS
17 insider filings · Latest: Apr 24, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | Mar 19 7:03 PM | Bobak R. AzamianDirector, President/CEO and Board Chair | Sale | 11,667 | $68.71 | $801.6K | 45,385(D) | View → |
| Mar 17, 2026 | Mar 19 7:03 PM | Bobak R. AzamianDirector, President/CEO and Board Chair | Sale | 10,972 | $69.42 | $761.7K | 57,052(D) | View → |
| Mar 16, 2026 | Mar 18 4:11 PM | Phd J Link WilliamDirector | Sale | 12,500 | $68.79 | $859.8K | 116,332(D) | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 24, 2026 | Apr 28 4:23 PM | I E Pyott DavidDirector | Option Exercise | 1,383 | — | 0(D) | View → |
| Mar 15, 2026 | Mar 17 4:40 PM | Dianne C. WhitfieldChief Human Resources Officer | Option Exercise | 23,909 | — | 15,067(D) | View → |
| Mar 15, 2026 | Mar 17 4:38 PM | Bryan WahlGeneral Counsel | Option Exercise | 24,236 | — | 15,067(D) | View → |
| Mar 15, 2026 | Mar 17 4:35 PM | Seshadri NeervannanChief Operating Officer | Option Exercise | 26,287 | — | 15,067(D) | View → |
| Mar 15, 2026 | Mar 17 4:32 PM | Aziz MottiwalaChief Commercial Officer | Option Exercise | 26,482 | — | 16,574(D) | View → |
| Mar 15, 2026 | Mar 17 4:27 PM | Jeffrey S FarrowChief Financial Officer and Chief Strategy Officer | Option Exercise | 13,042 | — | 15,067(D) | View → |
| Mar 15, 2026 | Mar 17 4:24 PM | Bobak R. AzamianDirector, President/CEO and Board Chair | Option Exercise | 66,274 | — | 44,634(D) | View → |
| Mar 15, 2026 | Mar 17 4:20 PM | Elizabeth Yeu LinChief Medical Officer | Option Exercise | 2,511 | — | 7,534(D) | View → |